CN101199667A - Chinese medicine for treating leukemia, aplastic anemia - Google Patents
Chinese medicine for treating leukemia, aplastic anemia Download PDFInfo
- Publication number
- CN101199667A CN101199667A CNA2007101591418A CN200710159141A CN101199667A CN 101199667 A CN101199667 A CN 101199667A CN A2007101591418 A CNA2007101591418 A CN A2007101591418A CN 200710159141 A CN200710159141 A CN 200710159141A CN 101199667 A CN101199667 A CN 101199667A
- Authority
- CN
- China
- Prior art keywords
- medicine
- formulation
- aplastic anemia
- herba
- assistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the Chinese traditional medicine technical field, relating to a Chinese herbal preparation for treating leukaemia and aplastic anemia. The invention is characterized in that the preparation includes A, B, C and D four formulations for matched taking; wherein, the formulation A is the main prescription drug whose raw materials contains datura flower, white vitriol and liquorice which are prepared into powder capsules; the formulation B is the first assistant prescription drug, the formulation C is the second assistant prescription drug and both the formulations B and C are prepared into powder capsules; the formulation D is the third assistant prescription drug which is decocted in water and prepared into decoction. The invention can give a temporary solution and ensure a permanent cure to the patients who are ill with leukaemia and undergo clinical hyperpyrexia, or are ill with cardiac failure or need regular blood enriching. After the Chinese traditional medicine typing, and the diagnoses and the treatments based on the overall analyses of the illnesses and 1000 patient's conditions, the results show that the total effective rate can reach more than 99 percent and the cure rate can reach more than 95 percent; besides, the invention also has good treatment effect to aplastic anemia.
Description
Technical field
The present invention is a technical field of Chinese medicines, relates to a kind of Chinese medicine preparation for the treatment of leukemia, aplastic anemia.
Background technology
Leukemia claims leukemia again, it is the pernicious disease of not controlling that jeopardizes the human life, tradition to the improvement of this disease comparatively effective method be: doctor trained in Western medicine adopts bone marrow or hematopoietic stem cell transplantation, but because adaptive bone marrow or the hematopoietic stem cell source is limited, expense is high, success rate is low, and its application is restricted; The doctor trained in Western medicine employing is put, chemotherapeutic treatment, and toxicity, side effect is big, though can kill a large amount of outgrowth leukocyte, has destroyed the immunologic function of human body, easily recurrence, and weak curative effect can not effect a radical cure.
Summary of the invention
The objective of the invention is to be diseases such as treatment leukemia, aplastic anemia, provide a kind of short treating period, curative effect height, medical expense low, have no adverse reaction and the Chinese medicine preparation of side effect.
A kind of Chinese medicine preparation content Description for the treatment of leukemia, aplastic anemia of the present invention:
A kind of Chinese medicine preparation for the treatment of leukemia, aplastic anemia of the present invention is characterized in that: it is divided into A, B, the supporting Chinese medicine preparation of taking of four kinds of models of C, D;
A type medicine is a main formula, and its crude drug is formed and weight is: Folium daturae 100g, Alumen 100g, Radix Glycyrrhizae 100g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated;
The Type B medicine is medicine of assistant formula, and its crude drug is a Herba Convallariae, and weight is 500g, is crushed to 120 order fine powders, sieves, to make powder encapsulated;
C type medicine is No. two medicines of assistant formula, its crude drug is formed and weight is: yangtao actinidia root bark 30g, terrible sword plumage 30g, Cortex walnut 10g, white bent dish 15g, Radix gynurae segeti 50g, Olibanum 10g, Myrrha 10g, Radix Angelicae Sinensis 10g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 10g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated;
D type medicine is No. three medicines of assistant formula, and its crude drug is formed and weight is: yangtao actinidia root bark 10g, terrible sword plumage 30g, Cortex walnut 15g, white bent dish 30g, Radix gynurae segeti 5g, Herba speranskiae tuberculatae 15g, Herba cassiae occidentalis 30g, LUBACAO 3g become decoction with decocting.
But the present invention is to treatment leukemia clinical hyperpyrexia, heart failure, the patient's treating both the principal and secondary aspects of a disease that need often enrich blood, carry out the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs of traditional Chinese medical science typing by example surplus clinical 1000, the result proves that total effective rate can reach more than 99%, cure rate reaches more than 95%, and aplastic anemia is had good therapeutic effect too.
The specific embodiment
A kind of Chinese medicine preparation for the treatment of leukemia, aplastic anemia of the present invention, it is divided into A, B, the supporting Chinese medicine preparation of taking of four kinds of models of C, D;
A type medicine is a main formula, and its crude drug is formed and weight is: Folium daturae 100g, Alumen 100g, Radix Glycyrrhizae 100g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated;
The Type B medicine is medicine of assistant formula, and its crude drug is a Herba Convallariae, and weight is 500g, is crushed to 120 order fine powders, sieves, to make powder encapsulated;
C type medicine is No. two medicines of assistant formula, its crude drug is formed and weight is: yangtao actinidia root bark 30g, Ramulus Euonymi 30g, Cortex walnut 10g, Herba Chelidonii 15g, Radix gynurae segeti 50g, Olibanum 10g, Myrrha 10g, Radix Angelicae Sinensis 10g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 10g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated.
Instructions about how to take medicine: A type main formula Drug Capsule, day clothes secondary, early, evening each capsules.
Drug Capsule of Type B assistant formula, day clothes secondary, early, evening each two capsules.
No. two Drug Capsules of C type assistant formula, day obeys once, two capsules.
D type medicine is No. three medicines of assistant formula, its crude drug is formed and weight is: yangtao actinidia root bark 10g, Ramulus Euonymi 30g, Ramulus Juglandis 15g, Herba Chelidonii 30g, Radix gynurae segeti 5g, Herba speranskiae tuberculatae 15g, Herba cassiae occidentalis 30g, LUBACAO 3g, be six times on the three dosage, the fried one-tenth decoction of water, begin to take day clothes secondary after taking ten at A, B, C type preparation capsule.
The present invention can remove medicine originality antigen body by A type main formula medicine, recovers hemopoietic function.By Drug Capsule of Type B assistant formula, be used for heart tonifying, the treatment heart failure, the heart tonifying diuretic that can activate yang improves cardiac function.By No. two Drug Capsule antitumor of C type assistant formula, by No. three medicine decoctions of D type assistant formula antitumor, eliminate edema, activating YANG for promoting diuresis, improve renal function.The leukaemic serve on one month and can recover hemopoietic function, can fully recover through treatment in two months, and aplastic anemia is had good therapeutic effect too.
Claims (1)
1. Chinese medicine preparation for the treatment of leukemia, aplastic anemia, it is characterized in that: it is divided into A, B, the supporting Chinese medicine preparation of taking of four kinds of models of C, D;
A type medicine is a main formula, and its crude drug is formed and weight is: Folium daturae 100g, Alumen 100g, Radix Glycyrrhizae 100g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated;
The Type B medicine is medicine of assistant formula, and its crude drug is a Herba Convallariae, and weight is 500g, is crushed to 120 order fine powders, sieves, to make powder encapsulated;
C type medicine is No. two medicines of assistant formula, its crude drug is formed and weight is: yangtao actinidia root bark 30g, Ramulus Euonymi 30g, Cortex walnut 10g, Herba Chelidonii 15g, Radix gynurae segeti 50g, Olibanum 10g, Myrrha 10g, Radix Angelicae Sinensis 10g, Radix Salviae Miltiorrhizae 10g, Rhizoma Chuanxiong 10g, said medicine is selected, dry, be crushed to 120 order fine powders, sieve, to make powder encapsulated;
D type medicine is No. three medicines of assistant formula, and its crude drug is formed and weight is: yangtao actinidia root bark 10g, Ramulus Euonymi 30g, Ramulus Juglandis 15g, Herba Chelidonii 30g, Radix gynurae segeti 5g, Herba speranskiae tuberculatae 15g, Herba cassiae occidentalis 30g, LUBACAO 3g become decoction with decocting.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101591418A CN101199667A (en) | 2007-12-24 | 2007-12-24 | Chinese medicine for treating leukemia, aplastic anemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101591418A CN101199667A (en) | 2007-12-24 | 2007-12-24 | Chinese medicine for treating leukemia, aplastic anemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101199667A true CN101199667A (en) | 2008-06-18 |
Family
ID=39515149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101591418A Pending CN101199667A (en) | 2007-12-24 | 2007-12-24 | Chinese medicine for treating leukemia, aplastic anemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101199667A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843656A (en) * | 2010-05-20 | 2010-09-29 | 刘洪凤 | External medicinal liquor for treating cancer and preparation method thereof |
| CN102526591A (en) * | 2012-01-16 | 2012-07-04 | 殷永洲 | Special effect Chinese herbal medicine composition for treating leukemia |
| CN102670859A (en) * | 2012-01-31 | 2012-09-19 | 河南科技大学 | Topical traditional Chinese medicinal composition for preventing and treating sarcomas |
-
2007
- 2007-12-24 CN CNA2007101591418A patent/CN101199667A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843656A (en) * | 2010-05-20 | 2010-09-29 | 刘洪凤 | External medicinal liquor for treating cancer and preparation method thereof |
| CN102526591A (en) * | 2012-01-16 | 2012-07-04 | 殷永洲 | Special effect Chinese herbal medicine composition for treating leukemia |
| CN102670859A (en) * | 2012-01-31 | 2012-09-19 | 河南科技大学 | Topical traditional Chinese medicinal composition for preventing and treating sarcomas |
| CN102670859B (en) * | 2012-01-31 | 2013-08-14 | 河南科技大学 | Topical traditional Chinese medicinal composition for preventing and treating sarcomas |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (en) | Chinese medicinal preparation for treating cancer and preparation method thereof | |
| CN102000262B (en) | Body-building traditional Chinese medicine for conditioning spleen-kidney yang deficiency sub-health | |
| CN1772196A (en) | Heart failure regulating Chinese medicine | |
| CN103223131B (en) | Liver disease drug | |
| CN101199667A (en) | Chinese medicine for treating leukemia, aplastic anemia | |
| CN105362904A (en) | Qi tonifying and blood nourishing traditional Chinese medicinal pill and preparation method thereof | |
| CN102416145A (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN102078559A (en) | Chinese medicinal composition with functions of tonifying kidney and strengthening brain | |
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
| CN101537114B (en) | Chinese medicine for treating arrhythmia | |
| CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN104435545A (en) | Traditional Chinese medicine preparation for treating leucopenia caused by benzene poisoning | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101537068B (en) | Chinese medicine for treating angina | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN102406843A (en) | Chinese medicinal composition for treating coronary disease | |
| CN102430026A (en) | Medicine for removing macula | |
| CN101396468B (en) | Traditional Chinese medicine for treating diabetes coronary heart disease | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis | |
| CN1314175A (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080618 |